Assess lot-to-lot consistency of 3 lots (double blind design) of GlaxoSmithKline Biologicals' 10-valent pneumococcal vaccine and evaluate non-inferiority to Prevenarâ„¢ (single blind design) when administered as 3-dose primary immunization course before 6 months of age
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Infections, Streptococcal
Phase 3
Follow on studies 107046, 112640, 111345,111346, and 111347 were conducted. An annotated case report form is not available for this study. A blank case report form will be provided.
October 2014